nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-3F2D4426·Framework v5.0·Pipeline v0.4·Evaluated 09 Jul 2026·OECD: 3.2 Clinical medicine·Subfield: Molecular Biology·Basis: Full text·Type: Laboratory experiment

CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression

Min-Cheng Yu et al.Min-Cheng Yu, Guang-Yu Ding, Peng Ma et al.·2021·10.1093/carcin/bgab068 ↗

In brief

A competent circRNA mechanism study that extends HCC biology, but remains constrained by single-center validation.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Abstract

Circular RNAs (circRNAs) are a class of regulatory RNAs with complex roles in healthy and diseased tissues. However, the oncogenic role of circRNAs in hepatocellular carcinoma (HCC) remains poorly understood, including the mechanisms by which the circular ubiquitin-binding associated protein 2 (circUBAP2) contributes to tumorigenesis. We analyzed the expression of circUBAP2 in 20 paired samples of HCC and healthy tissue as well as in seven HCC cell lines via quantitative real-time polymerase chain reaction. Functional experiments, such as CCK8 viability assays, colony formation assays, wound healing, transwell assays and flow cytometry, were conducted to assess the effects of circUBAP2 in vitro. To further elucidate the mechanisms by which circUBAP2 acts, we conducted dual-luciferase assays, western blots, RNA pull-down assays and rescue experiments. CircUBAP2 was highly upregulated in most HCC tissues and was associated with poor prognosis. HCC patients with high circUBAP2 expression had greater vascular invasion and worse differentiation. Functionally, circUBAP2 overexpression enhanced HCC cell proliferation, migration and invasion and inhibited apoptosis. Furthermore, we found that circUBAP2 upregulated c-Myc expression by sponging miR-1294, thus contributing to hepatocarcinogenesis. Inhibiting circUBAP2 expression in HCC attenuated the oncogenic effects of c-Myc. These findings suggest that circUBAP2 promotes HCC growth and metastasis. CircUBAP2 may have value as an independent prognostic biomarker or as a new target for the treatment of HCC.

Strengths · Limitations

Strengths

#methodological rigour

Mechanism tested through multiple assays

The proposed sponge mechanism is supported by cytoplasmic localization, luciferase assays, AGO2 RIP, miRNA pull-down, circRNA pull-down, western blotting, and rescue experiments. This provides more triangulation than a simple expression-association study.

↳ Results pp.7-9; Figures 4-6

#application pathway

Clinical association adds translational relevance

The study measures circUBAP2 in 125 HCC tissues and reports associations with overall survival, time to recurrence, vascular invasion, and differentiation. Multivariate Cox analyses report circUBAP2 as independently associated with TTR and OS.

↳ Results p.6; Tables 1-3

#contribution

Clear disease-context novelty claim

The discussion distinguishes prior circUBAP2 work in other cancers and frames the HCC-specific circUBAP2/miR-1294/c-Myc axis as the gap addressed here. That makes the contribution legible even though the mechanism class is familiar.

↳ Discussion pp.9-10; References 22-31

Limitations

#methodological rigour

External validation is not provided

The prognostic claim relies on a single-center surgical cohort and a 20-pair tissue validation subset. No independent cohort, patient-derived model, or broader clinical setting is used to test generalisability.

↳ Methods p.4; Results p.6; Figure 1

#methodological rigour

In vivo reporting lacks key details

The xenograft methods do not report group sizes, randomisation, blinding, or detailed statistical handling, and the text alternates between nude mice and NOG mice. This limits confidence in the animal-model evidence supporting the functional claims.

↳ Methods, Xenograft mouse model p.6; Results p.7; Figure 2F

#reporting

Reporting inconsistencies reduce precision

The results include a heading stating that circUBAP2 induces apoptosis even though the experiments indicate the opposite direction, and the figure legends contain panel-labeling and cross-reference inconsistencies. These do not overturn the main argument but weaken reporting reliability.

↳ Results pp.7-9; Figure 3 legend p.20; Figure 4 legend p.21

Does this match your read? Add your assessment ↓

Nabu Commentary

The quality score is driven by a competent mechanistic package linking circUBAP2 to miR-1294 and c-Myc through perturbation, binding, expression, and rescue experiments in HCC models. The clinical cohort and Cox analyses add relevance, but the single-center design and absence of external validation keep the contribution and impact in the moderate range. Methodological Rigour is constrained by sparse xenograft reporting, limited cell-model diversity, and generic statistical descriptions for multi-arm assays. Reporting is stronger than the methodological dimensions because the overall argument is easy to follow despite specific figure and heading errors.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.2±0.2

Contribution
3.2

The paper adds a circUBAP2/miR-1294/c-Myc axis in HCC and links expression to prognosis, which is a genuine disease-context contribution. The advance is incremental because circUBAP2, miR-1294, c-Myc, and circRNA-sponge mechanisms were already established in related cancer literature.

Background pp.3-4; Results pp.6-9; Discussion pp.9-10

no prior studies have examined the role of miR-1294 in HCC

Methodological Rigour
3.2

The study uses patient-expression analyses, two-cell-line perturbation experiments, xenografts, localization assays, luciferase assays, pull-down/RIP assays, and rescue experiments, which fit the mechanistic question. Methodological Rigour is limited by sparse xenograft reporting, single-center clinical data, limited model diversity, and generic statistical reporting.

Methods pp.4-6; Results pp.6-9; Tables 2-3; Figures 1-6

All functional experiments were conducted in triplicate.

Reporting
3.4

The paper’s progression from expression to function, mechanism, and rescue experiments is easy to follow. Reporting is reduced by a misleading apoptosis heading and figure-panel or cross-reference inconsistencies in Figures 3-4.

Results pp.7-9; Figure 3 legend p.20; Figure 4 legend p.21

CircUBAP2 promotes HCC cell proliferation and induces cell apoptosis

Positioning
3.3

The discussion connects the work to prior circRNA, circUBAP2, miR-1294, and c-Myc literature and notes the need for prospective validation. It does not deeply address the implications of the single-center cohort, lack of external validation, and limited experimental generalisability.

Discussion pp.9-10; References 19-41

further prospective cohort studies are required to validate the clinical value

Reliability

Caveats4 of 4 checks


Internal CoherenceNoted

The central circUBAP2/miR-1294/c-Myc mechanism is broadly coherent, but reporting precision is reduced by figure-labeling, cross-reference, animal-model, and statistical-description inconsistencies. These are watch-outs for interpretation and reproducibility rather than evidence that the core results are invalid.

Research ConductNoted

Human consent and human/animal ethics approvals are declared, but approval identifiers are not reported. Data availability is limited to an in-article statement, with no external repository or raw quantitative dataset identified.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 50 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Liver cancer
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesLarge
CitationsFWCI 2.0
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanistic claim is pinned down in controlled conditions, cell lines and xenograft mouse models, with only retrospective tissue expression data and no prospective clinical validation.

From the paper
“circUBAP2 may have value as an independent prognostic biomarker or as a new target for the treatment of HCC.”

The paper names possible real-world uses of its findings, a prognostic biomarker and a therapeutic target, but does not specify who would act on them or in what setting.

Pathway

Oncologists and drug developers could use circUBAP2 as a prognostic biomarker or therapeutic target for hepatocellular carcinoma after prospective validation.

Barrier

Prospective cohort studies and clinical development of circUBAP2-targeting interventions are still needed before any patient use.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Circular RNA Ubiquitin-associated Protein 2 Silencing Suppresses Bladder Cancer Progression by Downregulating DNA Topoisomerase 2-alpha Through Sponging miR-496

    Fu, Liu, Zhao, et al. · 2023 · Clinical medicine

    Evidence Score
    3.0±0.2
    Reliability
    Caveats
  2. CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma

    Liu, Tian, Chen, et al. · 2021 · Clinical medicine

    Evidence Score
    3.4±0.2
    Reliability
    Caveats
  3. Circular RNA UBAP2 contributes to tumor growth and metastasis of cervical cancer via modulating miR-361-3p/SOX4 axis

    Meng, Jia, Yu, et al. · 2020 · Basic medicine

    Evidence Score
    2.9±0.2
    Reliability
    Caveats

How the rubric works →